|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging kidney disease/toxicity, liver disease/toxicity and lung disease.There was no report of medical intervention.The manufacturer was made aware of this complaint through a representative of the customer.Maximum attempts were made to have the device returned for evaluation, investigation and to gather additional information.The device has been returned to manufacturer.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
|
|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging kidney disease/toxicity, liver disease/toxicity and lung disease.There was no report of medical intervention.The manufacturer was made aware of this complaint through a representative of the customer.The device was returned to the third-party service center for further evaluation.During the evaluation of the device at the third-party service center, the device was visually inspected and found no evidence of foam degradation.During the evaluation, secondary findings and dust was observed.The device powered on, and airflow was confirmed.The device's downloaded logs were reviewed by the third-party service center.There was no error code found.The third-party service center concludes that they couldn't confirm the customer's allegation and there was no visible foam degradation and unit corrected.Box h: evaluation method code, evaluation results code, component code grid and conclusion code grid has been updated.
|